Tandem Diabetes Care TNDM
NASDAQ TNDM
$22.58 -0.88 (-3.75%)
As of: Aug 20, 2026 · 3:59 PM EDT

Tandem Diabetes Care (TNDM) Other Operating Expenses (2013 - 2025)

Tandem Diabetes Care's (TNDM) quarterly Other Operating Expenses came in at $75.2 million in Q1 2025, up 7521800.0% on a QoQ basis from -$1000.0 in Q4 2024.

Tandem Diabetes Care (TNDM) Other Operating Expenses (2013 - 2025) Analysis & Trends

Tandem Diabetes Care (TNDM) has 8 years of Other Operating Expenses data on file, last reported at $75.2 million in Q1 2025.

  • Quarterly Other Operating Expenses changed N/A year-over-year to $75.2 million in Q1 2025, while the trailing twelve-month figure through Dec 2025 was $75.2 million (up 7521800.0% YoY) and the FY2025 annual result came in at $75.2 million, changed N/A from the prior year.
  • Other Operating Expenses grew to $75.2 million in Q1 2025, from -$1000.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $78.8 million in Q1 2023 to a low of -$1000.0 in Q4 2024.
  • A 4-year average of $37.0 million and a median of $31.0 million in 2022 frame the typical range for Other Operating Expenses.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn
10 Tandem Diabetes Care 1.56 Bn 1.10 Bn 144.78 Mn

Historic Data

Download Data
DateValue
Mar 31, 2025 75.22 Mn
Dec 31, 2024 -1,000.00
Mar 31, 2023 78.75 Mn
Dec 31, 2022 23,000.00
Sep 30, 2022 31.02 Mn
Dec 31, 2019 -1,000.00
Dec 31, 2017 -1,000.00
Dec 31, 2014 1,000.00
Jun 30, 2014 -1,000.00
Dec 31, 2013 2.00
Sep 30, 2013 -379.00
Jun 30, 2013 -70.00
Mar 31, 2013 446.00